Inhibitor Therapeutics, Inc.

INTI · OTC · SIC 2834: Pharmaceutical Preparations
310
SEC Filings

Business Summary

Inhibitor Therapeutics, Inc. (INTI) is a Delaware-incorporated biopharmaceutical company focused on developing and commercializing therapeutic product candidates. The company seeks to advance its pipeline through clinical trials requiring FDA or other regulatory approval, and pursues securing development and commercialization partners. Specific product candidates are not detailed in the provided section of the filing.

Next Earnings

Q2 FY2026 — expected 2026-08-21

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionINTIdiscussed_in_filing Cybersecurity
topic_mentionINTIdiscussed_in_filing Trusted Computing
topic_mentionINTIdiscussed_in_filing Blockchain & Crypto
topic_mentionINTIdiscussed_in_filing Regulation
topic_mentionINTIdiscussed_in_filing Healthcare & Bio
topic_mentionINTIdiscussed_in_filing Sovereign & Government
topic_mentionINTIdiscussed_in_filing Cybersecurity
topic_mentionINTIdiscussed_in_filing Trusted Computing
topic_mentionINTIdiscussed_in_filing Blockchain & Crypto
topic_mentionINTIdiscussed_in_filing Regulation
topic_mentionINTIdiscussed_in_filing Healthcare & Bio
topic_mentionINTIdiscussed_in_filing Sovereign & Government
topic_mentionINTIdiscussed_in_filing Cybersecurity
topic_mentionINTIdiscussed_in_filing Trusted Computing
topic_mentionINTIdiscussed_in_filing Blockchain & Crypto
topic_mentionINTIdiscussed_in_filing Regulation
topic_mentionINTIdiscussed_in_filing Healthcare & Bio
topic_mentionINTIdiscussed_in_filing Sovereign & Government
topic_mentionINTIdiscussed_in_filing Cybersecurity
topic_mentionINTIdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001493152-26-012751EDGAR39K words
2025-03-282024-12-310001641172-25-001190EDGAR—
2024-03-292023-12-310001493152-24-011973EDGAR—
2023-03-312022-12-310001493152-23-010383EDGAR—
2022-03-302021-12-310001193125-22-088832EDGAR—
2021-03-262020-12-310001193125-21-095516EDGAR—
2020-03-302019-12-310001193125-20-090201EDGAR—
2019-03-072018-12-310001193125-19-066503EDGAR—
2018-02-162017-12-310001193125-18-047834EDGAR—
2017-02-172016-12-310001193125-17-048025EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001493152-25-022178EDGAR11K words
2025-08-132025-06-300001641172-25-023465EDGAR—
2025-05-142025-03-310001641172-25-010110EDGAR—
2024-11-122024-09-300001493152-24-044473EDGAR—
2024-08-062024-06-300001493152-24-030381EDGAR—
2024-05-132024-03-310001493152-24-018805EDGAR—
2023-11-132023-09-300001493152-23-040351EDGAR—
2023-08-112023-06-300001493152-23-027740EDGAR—
2023-05-152023-03-310001493152-23-016967EDGAR—
2022-11-142022-09-300001193125-22-284610EDGAR—
2022-08-122022-06-300001193125-22-219960EDGAR—
2022-05-132022-03-310001193125-22-149504EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001493152-26-014637EDGAR1K words
2026-04-010001493152-26-014517EDGAR—
2026-02-240001493152-26-007821EDGAR—
2025-10-270001493152-25-019381EDGAR—
2023-12-140001193125-23-294696EDGAR—
2023-10-180001193125-23-258156EDGAR—
2023-08-290001193125-23-223590EDGAR—
2023-05-310001493152-23-019651EDGAR—
2022-12-190001193125-22-308415EDGAR—
2022-09-150001193125-22-245701EDGAR—

310 total filings indexed. 278 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

biopharmaceuticals drug-development

Company Identity

CIK0001042418
TickerINTI
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 375b10a0280fac041442a3df9964c606f9e7ea7812c930d3768d8b9d5f9330e6
parent: 3b0c2a845e4213e3cc6f42816541ece11453fa7c6513a69d01ea88bcad616ab2
content hash: b801010b70ac85c0a56046c233af84c0bf8e07291e19da354f91478b0688ef1f
signed: 2026-04-13T04:45:42.929Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf